Cancer Immunotherapy in Multiple Myeloma by Adoptive Transfer of CD4+ T cells: from Mouse to Man
- Prosjektnummer
- 2009066
- Ansvarlig person
- Bjarne Bogen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 3. Prevention
Molecular profiling of tumor-specific TH1 cells activated in vivo.
Oncoimmunology 2013 May 1;2(5):e24383.
PMID: 23762808 - Inngår i doktorgradsavhandlingen
Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice.
Blood 2012 Mar;119(9):2176-7.
PMID: 22383793 - Inngår i doktorgradsavhandlingen
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.
Nat Commun 2011;2():240.
PMID: 21407206 - Inngår i doktorgradsavhandlingen
Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer.
Scand J Immunol 2011 Jun;73(6):527-30.
PMID: 21388431
Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Cancer Res 2009 Jul;69(14):5901-7. Epub 2009 jun 30
PMID: 19567679
En betennelsesreaksjon kan beskytte mot kreft
NBS nytt, nr. 6/2011
Fremtidens kreftbehandling: Betennelse bekjemper kreft
Apollon
Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice
Blood, in press
Proteomics of tumor-specific CD4+ T cells
International immunology meeting abstracts (2010) 22
Tumor-specific inflammation protects against cancer
International immunology meeting abstracts (2010) 22
Inflammation mediated by tumor-specific Th1 or Th2 cells protects against B-cell cancer
- Disputert:
- desember 2013
- Hovedveileder:
- Bjarne Bogen
- Alexandre Corthay Forsker (annen finansiering)
- Kristina Berg Lorvik Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport